The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis

Our results suggest that platelets of patients with intracoronary stent restenosis with or without PlA2 heterozygosity of glycoprotein IIIa are more likely to be resistant to low-dose aspirin therapy.